Showing results (401-410 of 510) with videos related to
Sort By:
Pageof 51
British Journal of Pharmacology|November 1, 1990
A novel series of non-quaternary oxadiazoles acting as full agonists at muscarinic receptorsS B Freedman, E A Harley, S Patel, et al.British Journal of Pharmacology|October 1, 1992
L-689,660, a novel cholinomimetic with functional selectivity for M1 and M3 muscarinic receptorsR J Hargreaves, A T McKnight, K Scholey, et al.Cell and Tissue Research|January 1, 1981
Immunohistochemical localization of the catecholamine-synthesizing enzymes, substance P and enkephalin in the human fetal sympathetic ganglionA Hervonen, V M Pickel, T H Joh, et al.Insect Molecular Biology|October 7, 2008
Microarray analysis of acaricide-inducible gene expression in the southern cattle tick, Rhipicephalus (Boophilus) microplusL Saldivar, F D Guerrero, R J Miller, et al.Veterinary Parasitology|March 13, 2009
In vitro tests to establish LC50 and discriminating concentrations for fipronil against Rhipicephalus (Boophilus) microplus (Acari: Ixodidae) and their standardizationE Castro-Janer, L Rifran, J Piaggio, et al.The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society|September 21, 2013
Distribution of MT1 melatonin receptor promoter-driven RFP expression in the brains of BAC C3H/HeN transgenic miceE B Adamah-Biassi, Y Zhang, H Jung, et al.Proceedings of the National Academy of Sciences of the United States of America|November 25, 1998
Chemokines regulate hippocampal neuronal signaling and gp120 neurotoxicityO Meucci, A Fatatis, A A Simen, et al.BMJ (Clinical Research Ed.)|March 26, 1994
Long term acid suppressing treatment in general practiceS D Ryder, S O'Reilly, R J Miller, et al.International Journal of Cardiology|November 30, 2010
Effect of heart rate reduction by ivabradine on left ventricular remodeling in the echocardiographic substudy of BEAUTIFULC Ceconi, S B Freedman, J C Tardif, et al.Bioorganic & Medicinal Chemistry|September 1, 1994
Selective non-peptide ligands for an accommodating peptide receptor. Imidazobenzodiazepines as potent cholecystokinin type B receptor antagonistsM G Bock, R M DiPardo, R C Newton, et al.Pageof 51